Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Riluzole augmentation for treatment-resistant depression

Gerard Sanacora, Steven F Kendell, Lisa Fenton

    The American Journal of Psychiatry
    |October 30, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Using connectome-based predictive models to reveal the systems standardized tests and clinical symptoms are reflecting.

    Nature communications·2026
    Same author

    Lower synaptic density in mood circuitry underlies depression in Parkinson's disease.

    Brain communications·2026
    Same author

    Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial.

    The Journal of clinical psychiatry·2026
    Same author

    The American Society of Clinical Psychopharmacology (ASCP) task force on the deprescribing of psychotropic medications for mood disorders: Delphi expert consensus.

    The British journal of psychiatry : the journal of mental science·2026
    Same author

    Phase 2 Clinical Trial of MK-1942, a Negative Allosteric Modulator of Metabotropic Glutamate Receptor 2, for Treatment-Resistant Depression.

    Journal of clinical psychopharmacology·2026
    Same author

    Comment on Esketamine 5 Years After Approval: Welcome New Data With Continuing Questions.

    The American journal of psychiatry·2026